Evidence map›Paper›PMID 41098929›Full record

ReviewComprehensive psychoneuroendocrinology2025

Embracing change: Navigating menopause with the help of mobile health apps in Germany.

Klara Greffin, Marlene Muehlmann, Anna Pauleikhoff, Bita Stelling, Holger Muehlan, Michael Stach, Silke Schmidt, Samuel Tomczyk

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Comprehensive psychoneuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Klara GreffinUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Marlene MuehlmannUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Anna PauleikhoffUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Bita StellingUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Holger MuehlanUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Michael StachInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Silke SchmidtUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.
Samuel TomczykUniversity of Greifswald, Institute of Psychology, Department Health and Prevention, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mobile health applications (mHealth apps) have shown promise as potential solutions for mitigating the negative health impacts of menopause. However, there is a lack of standardized expert and user ratings regarding the quality of these apps, making it difficult to provide evidence-based recommendations. Therefore, this app review aimed to summarize the currently available mHealth apps for menopause in Germany. Subsequently, the identified apps were evaluated, and their quality was assessed. Methods: A web crawler was used to search for mHealth apps related to the predefined search criteria, and information for all included apps was extracted (year of search: 2021). In the second step, healthcare providers and individuals experiencing menopause tested and evaluated the apps using the German version of the Mobile Application Rating Scale (MARS-G). Results: The initial search yielded 6917 apps. Of these, 6879 were excluded, 32 duplicates were removed, three were available only in English, and one was designed for a specific drug treatment. The two remaining apps, Femilog and Mimeno, received low expert ratings ( Conclusion: This app review identified two mHealth apps for menopause in German that met the inclusion criteria. Both apps were found to have poor perceived therapeutic gain and received mixed ratings and recommendations from experts and users. Further studies on user experience and efficacy are necessary to make evidence-based recommendations regarding mHealth apps for individuals experiencing menopause.

Indexed as

App reviewClimactericDigital health applicationEvaluationMenopausemHealthSmartphone appsTelemedicineWomen's health

Identifiers

PMID41098929
PMCPMC12519169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.